In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Ideaya Biosciences Inc (NASDAQ: IDYA) was $24.33 for the day, down -0.16% from the previous closing price of $24.37. In other words, the price has decreased by -$0.16 from its previous closing price. On the day, 1.01 million shares were traded. IDYA stock price reached its highest trading level at $24.605 during the session, while it also had its lowest trading level at $23.84.
Ratios:
Our analysis of IDYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.39 and its Current Ratio is at 12.39. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On June 26, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $44.Wells Fargo initiated its Overweight rating on June 26, 2025, with a $44 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2132371072 and an Enterprise Value of 1489229824. For the stock, the TTM Price-to-Sale (P/S) ratio is 304.62 while its Price-to-Book (P/B) ratio in mrq is 2.22. Its current Enterprise Value per Revenue stands at 212.747 whereas that against EBITDA is -3.901.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.12, which has changed by -0.37711215 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $40.74, while it has fallen to a 52-week low of $13.45. The 50-Day Moving Average of the stock is 7.13%, while the 200-Day Moving Average is calculated to be 8.89%.
Shares Statistics:
IDYA traded an average of 1.13M shares per day over the past three months and 959430 shares per day over the past ten days. A total of 87.64M shares are outstanding, with a floating share count of 80.63M. Insiders hold about 8.13% of the company’s shares, while institutions hold 104.13% stake in the company. Shares short for IDYA as of 1753920000 were 10120270 with a Short Ratio of 8.97, compared to 1751241600 on 11584970. Therefore, it implies a Short% of Shares Outstanding of 10120270 and a Short% of Float of 13.62.
Earnings Estimates
The current rating of Ideaya Biosciences Inc (IDYA) is the result of assessments by 12.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.61 and low estimates of -$1.03.
Analysts are recommending an EPS of between -$3.0 and -$3.62 for the fiscal current year, implying an average EPS of -$3.36. EPS for the following year is -$3.24, with 13.0 analysts recommending between -$2.4 and -$4.15.
